Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Graves’ Orbitopathy
source: Family Practice Notebook
year: 2021
summary/abstract:Epidemiology:
Eye complications occur in 25-50% of Grave’s disease.
Pathophysiology:
Grave’s disease induced eye changes:
• Sensitized orbital tissue-specific T-Lymphocytes
• Local inflammatory cellular infiltration of eye
Orbital fibroblasts mediate changes:
• Adipose hypertrophy
• Glycosaminoglycan accumulates
Residual scarring may cause irreversible proptosis.
Risk Factors:
Tobacco abuse (Relative Risk 3.7)
Older men appear to have more severe cases
Radioiodine therapy may cause flare in eye disease
• Prednisone used to prevent flare
– Dose: 40 to 80 mg daily
– Taper off over 3 months.
read more
Related Content
-
Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active ...Horizon Pharma plc today announced topli...
-
ENFOQUE en la salud ocularhttps://www.onegravesvoice.com/wp-conten...
-
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseBackground: Thyroid eye disease is a de...
-
Enfermedad De Graves en Bebés Recién Nacido¿Cuáles Son las Causas de La Enfermeda...
-
The Relaxation Responses – Dr. Herbert Bensonhttps://www.youtube.com/watch?v=Mea202U9...
-
A Pain in the Neck: News Reporting on Graves’ DiseaseMany different illnesses exist, and it i...
-
Anatomic Considerations in Thyroid Eye DiseasePurpose: To review and summarize the cl...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.